The Role of Negative Emotions, Mental Rumination, And Behavioral Inhibition System In prediction Of the Symptoms of Premenstrual dysphoric Disorder among Female Students of Azarbaijan Shahid Madani University in 2015

Document Type : Original Article

Authors

1 PhD, Dept of Psychology, Azarbaijan Shahid Madani University, Tabriz, Iran

2 PhD, Dept of Psychology, Azarbaijan Shahid Madani University, Tabriz, Iran.

3 MSc, Dept of General Psychology, Shahid Madani University of Azerbaijan, Tabriz, Iran.

Abstract

Introduction: Premenstrual dysphoric Disorder (PMDD) is a mental - physical disease initiated by changing the levels of sex steroids in menstrual–ovulation cycle. Thus, the present study was conducted aiming to investigate the role of negative emotions, mental rumination, and Behavioral Inhibition System in prediction of the symptoms of premenstrual Dysphoric Disorder in female students of Azarbaijan Shahid Madani University in 2015.
Materials and Methods: The statistical population of this descriptive study included all female students of Azarbaijan Shahid Madani University in 2015. Using a Convenience Sampling method, 267 students were selected for   this study. Research tools were; the Premenstrual Symptoms Screening Tool (PSST), Five-Factor Jackson Personality Inventory, Penn State Worry, Rumination, the Beck Depression -II (BDI-II), and the Beck Anxiety (BAI). Data was analyzed using regression method by applying Path Analysis Method.
Results: The findings of the present research depicted that anxiety with explanation force of about 29/2 percent (p=0/001, β=0/435) and depression with explanation force of 27 (p=0/001, β=0/356), and also variables of mental rumination  (p=0/001, β=0/171), behavioural inhibition  (p=0/001, β=0/213), and worry (p=0/001, β=0/142) were significant in the prediction of symptoms regarding Premenstrual Dysphoric Disorder.
Conclusion: The results of this study illustrated that variables of anxiety, depression, worry, mental rumination, and behavioural inhibition are associated with the symptoms of Premenstrual Dysphoric Disorder. These results proved the significance of paying more attention to the mental health of students and also designing more efficient practical plans for promotion of mental health-related issues is of paramount importance.  

Keywords


  1. Faingold C, Blumenfeld H. Neuronal networks in brain function, CNS disorders, and therapeutics. 2nd ed.  New York :Oxford; 2013: 179-92.
  2. O'Brien PS, Rapkin A, Schmidt PJ. The premenstrual syndromes: PMS and PMDD. 2nd ed. United Kingdom: Informa Healthcare; 2007: 9-69.
  3. Cheng S-H, Shih C-C, Yang Y-K, Chen K-T, Chang Y-H, Yang Y-C. Factors associated with premenstrual syndrome—A survey of new female university students. KJMS 2013;29(2):100-5.
  4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5®).5nd ed.   New York: Springer; 2013: 195-9.
  5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Health Disorders (DSM-III-R). 3nd ed.  New York: Springer; 1987: 489-99.
  6. Epperson CN, Steiner M, Hartlage SA, Eriksson E, Schmidt PJ, Jones I, et al. Premenstrual dysphoric disorder: evidence for a new category for DSM-5. AJP 2012;169(5):465-75.
  7. Ko C-H, Long C-Y, Chen S-YCI-J, Huang T-H, Yen J-Y. Depression, irritability, and anxiety in women with premenstrual dysphoric disorder. IJPM 2013;46(1):39-55.
  8. Clark LA, Watson D. Mood and the mundane: Relations between daily life events and self-reported mood. JPSP 1988;54(2):296-308.
  9. Boland EM, Stange JP, LaBelle DR, Shapero BG, Weiss RB, Abramson LY, et al. Affective disruption from social rhythm and Behavioral Approach System (BAS) sensitivities: A test of the integration of the social zeitgeber and BAS theories of bipolar disorder. CPS 2016;4(3):418-32.
  10. Ko CH, Long CY, Yen CF, Chen CS, Wang PW, Yen JY. Gonadotrophic hormone and reinforcement sensitivity systems in women with premenstrual dysphoric disorder. PCN 2014;68(11):785-94.
  11. Hantsoo L, Epperson CN. Premenstrual dysphoric disorder: epidemiology and treatment. CPR 2015;17(11):87.
  12. Rezaei-Adryani M, Azadi A, Ahmadi F, Azimi A. Comparison level of stress, Anxiety, Depression and quality of life in dormitory resident students. IJNR 2007;4(2):31-8. [Persian]
  13. Steiner M, Macdougall M, Brown E. The premenstrual symptoms screening tool (PSST) for clinicians. AWMH 2003;6(3):203-9.
  14. Siahbazi SH, Hariri F, Montazeri A, Moghdam BL. Standardized screening questionnaires PMS PSST: translation and psychometric Iranian version. Payesh2011; 10 (4): 421-7. [Persian]
  15. Jackson CJ. Jackson-5 scales of revised Reinforcement Sensitivity Theory (r-RST) and their application to dysfunctional real world outcomes. JRP 2009;43(4):556-69.
  16. Hussaini J, Salehi S, Rasouli AM. Psychometric properties of five factor questionnaire. JRPH 2012; 6 (3):60-73. [Persian]
  17. Molina S, Borkovec TD. The Penn state worry questionnaire: Psychometric properties and associated characteristics. 2nd ed. England: John Wiley & Sons; 1994:265–83.
  18. Borjali A, Sohrabi F, Dehshiri G, Golzari M. Psychometrics particularity of farsi version of Pennsylvania state worry questionnaire for college students. Applied Psychology 2010;4(1):67-75. [Persian]
  19. Ghorbani N, Watson P, Hargis MB. Integrative Self-Knowledge Scale: Correlations and incremental validity of a cross-cultural measure developed in Iran and the United States. The Journal of Psychology 2008;142(4):395-412
  20. Rajabi Gh, Karju-kasmai S. Psychometric properties of a Persian‐language version of the Beck Depression Inventory‐Second edition: BDI‐II‐PERSIAN. Depression and anxiety. 2005;21(4):185-92. [Persian]
  21. Fathi Ashtiani A, Dastaney M. Psychological testing and personality assessment mission Rvan.antsharat health. 9nd ed. Tehran: Besat; 2012: 250-400. [Persian]
  22. Baron RM, Kenny DA. The moderator–mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. JPSP1986;51(6):1173-82.
  23. Rasul-Zadeh M.(dissertation). The role of hybrid model to predict the nature of emotional disorders symptoms of depression based on DSM-V. Tabriz: Shahid Madani University of Azerbaijan; 2014:95-105. [Persian]
  24. Landen M, Eriksson E. How does premenstrual dysphoric disorder relate to depression and anxiety disorders? Depression and Anxiety 2003;17(3):122-9.
  25. Yonkers KA, O'Brien PS, Eriksson E. Premenstrual syndrome. The Lancet 2008;371(9619):1200-10.
  26. Pigott TA. Anxiety disorders in women. PCNA 2003;26(3):621-72.
  27. Greenberg PE, Sisitsky T, Kessler RC, Finkelstein SN, Berndt ER, Davidson JR, et al. The economic burden of anxiety disorders in the 1990s. JCP.1999;60(7):427-35.
  28. Smits JA, Berry AC, Powers MB, Greer TL, Otto MW. The promise of exercise interventions for the anxiety disorders.  Anxiety in health behaviors and physical illness. 2nd ed. New York: Springer; 2008: 81-104.
  29. Manikandan S, Nillni YI, Zvolensky MJ, Rohan KJ, Carkeek KR, Leyro TM. The role of emotion regulation in the experience of menstrual symptoms and perceived control over anxiety-related events across the menstrual cycle. AWMH 2016;19(6):1109-17.
  30. Graze K, Nee J, Endicott J. Premenstrual depression predicts future major depressive disorder. APS 1990;81(2):201-5.
  31. Balık G, Hocaoğlu Ç, Kağıtcı M, Güvenda Güven ES. Comparison of the effects of PMDD and pre-menstrual syndrome on mood disorders and quality of life: A cross-sectional study. JOG 2015;35(6):616-20.
  32. Batra P, Harper D. Recognizing and treating premenstrual dysphoric disorder. JCOM-WAYNE PA- 2002;9(2):87-99.
  33. Yonkers KA, Kornstein SG, Gueorguieva R, Merry B, Van Steenburgh K, Altemus M. Symptom-onset dosing of sertraline for the treatment of premenstrual dysphoric disorder: a randomized clinical trial. JAMA psychiatry 2015;72(10):1037-44.
  34. Nolen-Hoeksema S. Responses to depression and their effects on the duration of depressive episodes. JAP 1991;100(4):569.
  35. Gingnell M, Ahlstedt V, Bannbers E, Wikström J, Sundström-Poromaa I, Fredrikson M. Social stimulation and corticolimbic reactivity in premenstrual dysphoric disorder: a preliminary study. Biology of mood & anxiety disorders 2014;4(1):3.